Evergreen Nephrology

About Evergreen Nephrology

Evergreen Nephrology, founded in 2021, operates as a value-based kidney care organization, partnering with nephrologists to improve care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company was established by Adam Boehler, Abe Sutton, and Matt Kim and is headquartered in Nashville, Tennessee. Boehler's background includes serving as the Director of the Innovation Center at the Centers for Medicare & Medicaid Services (CMS), where he was instrumental in developing the kidney care models that empower nephrologists. This experience directly informs Evergreen's mission to shift the focus of kidney care from a fee-for-service model to a value-based system that prioritizes better patient outcomes.

The company's business model centers on forming strategic partnerships and joint ventures with nephrology practices. Evergreen provides these practices with financial backing, analytical insights, and a suite of interdisciplinary clinical resources. This support enables nephrologists to take on the financial risk associated with value-based care arrangements, particularly within programs like the Medicare Kidney Care Choices (KCC) model. Revenue is generated through these partnerships, which may include subscription-based services and performance-based contracts tied to quality metrics set by organizations like CMS. A significant milestone was achieved in January 2025, when the company raised $130 million in a Series D funding round led by Rubicon Founders and Oak HC/FT, with participation from K2 HealthVentures and other investors. This capital is intended to fuel expansion into new regions and the implementation of advanced technologies.

Evergreen's service offering provides nephrologists with a technology-enabled platform and a dedicated care team to augment patient care. This team includes nurse care managers, care coordinators, social workers, dietitians, and pharmacists who work collaboratively with the patient's primary nephrologist. The goal is to provide holistic, personalized care that addresses not only the physical but also the emotional and social aspects of living with kidney disease. By offering this wraparound support, Evergreen aims to slow disease progression, increase rates of home dialysis and kidney transplantation, reduce hospitalizations, and streamline the administrative burden on physicians, allowing them to focus on clinical care. The company operates in 24 states with a network of over 900 providers, demonstrating its expanding footprint in the U.S. healthcare landscape.